BACKGROUND AIMS: To date there are only very few data available on the ligamentogenic differentiation capacity of mesenchymal stromal/progenitor cells (MSC) and anterior cruciate ligament (ACL) fibroblasts. METHODS: We describe the in vitro potential of MSC and ACL cells to undergo ligamentogenic differentiation upon transduction with adenoviral vectors encoding the human cDNA for bone morphogenetic protein (BMP) 12 and BMP13, also known as growth and differentiation factors (GDF) 6 and 7, respectively. RESULTS: Transgene expression for at least 14 days was confirmed by Western blot analyzes. After 21 days of cell culture within collagen type I hydrogels, histochemical (hematoxylin/eosin (H&E), Azan and van Gieson), immunohistochemical and polymerase chain reaction (PCR) analyzes of the genetically modified constructs of both cell types revealed elongated, viable fibroblast-like cells embedded in a ligament-like matrix rich in collagens, vimentin, fibronectin, decorin, elastin, scleraxis, tenascin, and tenomodulin. CONCLUSIONS: It appears that both MSC and ACL fibroblasts are capable of ligamentogenic differentiation with these factors. This information may aid in the development of biologic approaches to repair and restore ACL after injury.
BACKGROUND AIMS: To date there are only very few data available on the ligamentogenic differentiation capacity of mesenchymal stromal/progenitor cells (MSC) and anterior cruciate ligament (ACL) fibroblasts. METHODS: We describe the in vitro potential of MSC and ACL cells to undergo ligamentogenic differentiation upon transduction with adenoviral vectors encoding the human cDNA for bone morphogenetic protein (BMP) 12 and BMP13, also known as growth and differentiation factors (GDF) 6 and 7, respectively. RESULTS: Transgene expression for at least 14 days was confirmed by Western blot analyzes. After 21 days of cell culture within collagen type I hydrogels, histochemical (hematoxylin/eosin (H&E), Azan and van Gieson), immunohistochemical and polymerase chain reaction (PCR) analyzes of the genetically modified constructs of both cell types revealed elongated, viable fibroblast-like cells embedded in a ligament-like matrix rich in collagens, vimentin, fibronectin, decorin, elastin, scleraxis, tenascin, and tenomodulin. CONCLUSIONS: It appears that both MSC and ACL fibroblasts are capable of ligamentogenic differentiation with these factors. This information may aid in the development of biologic approaches to repair and restore ACL after injury.
Authors: Arnulf Pascher; Andre F Steinert; Glyn D Palmer; Oliver Betz; Jean-Noel Gouze; Elvire Gouze; Carmencita Pilapil; Stephen C Ghivizzani; Christopher H Evans; Martha Meaney Murray Journal: Mol Ther Date: 2004-08 Impact factor: 11.454
Authors: N M Wolfman; G Hattersley; K Cox; A J Celeste; R Nelson; N Yamaji; J L Dube; E DiBlasio-Smith; J Nove; J J Song; J M Wozney; V Rosen Journal: J Clin Invest Date: 1997-07-15 Impact factor: 14.808
Authors: S J Martin; C P Reutelingsperger; A J McGahon; J A Rader; R C van Schie; D M LaFace; D R Green Journal: J Exp Med Date: 1995-11-01 Impact factor: 14.307
Authors: Carlos I Lorda-Diez; Ana Canga-Villegas; Luis Cerezal; Santiago Plaza; Juan M Hurlé; Juan A García-Porrero; Juan A Montero Journal: J Anat Date: 2013-10-16 Impact factor: 2.610
Authors: Andre F Steinert; Manuela Kunz; Patrick Prager; Thomas Barthel; Franz Jakob; Ulrich Nöth; Martha M Murray; Christopher H Evans; Ryan M Porter Journal: Tissue Eng Part A Date: 2011-03-08 Impact factor: 3.845
Authors: M Hoyer; C Meier; A Breier; J Hahner; G Heinrich; N Drechsel; M Meyer; C Rentsch; L-A Garbe; W Ertel; A Lohan; G Schulze-Tanzil Journal: Histochem Cell Biol Date: 2014-09-26 Impact factor: 4.304